General Notices

• Notice of Information: NINDS will increase the salary allowance for K00 awardees for NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
  (NOT-NS-24-016)
  National Institute of Neurological Disorders and Stroke
  

• Findings of Research Misconduct
  (NOT-OD-24-041)
  Office of the Director, NIH
  

• Request for Information (RFI): NCI Cancer Research Data Commons (CRDC) Artificial Intelligence (AI) use cases to inform an assessment of data readiness
  (NOT-CA-24-017)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice of NCI's participation in PAR-23-301, Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
  (NOT-CA-24-018)
  National Cancer Institute
  

• Notice of Change to PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
  (NOT-DA-23-049)
  National Institute on Drug Abuse
  

• Notice of NIEHS Increase in Salary Support for "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" Notice of Funding Opportunities
  (NOT-ES-24-003)
  National Institute of Environmental Health Sciences
  

• Notice of Change to First Application Due Date in PAR-23-221 "Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
  (NOT-GM-24-015)
  National Institute of General Medical Sciences
  

• Notice of Change to Receipt Dates for RFA-NS-22-069: "HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)"
  (NOT-NS-23-099)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for RFA-NS-24-023: HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3)
  (NOT-NS-24-029)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Notice of Funding Opportunity for Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities (R01)
  (NOT-NR-24-003)
  National Institute of Nursing Research
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
  (NOT-CA-24-016)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to NIGMS-Funded Awards for Building Cloud-Based Learning Modules
  (NOT-GM-24-006)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
  (NOT-OD-24-032)
  Office of Research on Women's Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  

Funding Opportunities

• Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical Trial Optional)
  (PA-24-093)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): January 19, 2029
  
  

• Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
  (PAR-23-318)
  John E. Fogarty International Center
  National Cancer Institute
  National Eye Institute
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Office of Dietary Supplements
  Office of Research on Women's Health
  Application Receipt Date(s): March 20, 2026
  
  

• Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)
  (PAR-24-038)
  National Institute of Dental and Craniofacial Research
  National Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): February 20, 2026
  
  

• Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
  (PAR-24-081)
  Office of the Director, NIH
  National Human Genome Research Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): March 13, 2026
  
  

• Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
  (RFA-CA-24-021)
  National Cancer Institute
  Application Receipt Date(s): March 06, 2024
  
  

• Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R01 Clinical Trial Not Allowed)
  (RFA-DA-25-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 14, 2024
  
  

• Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R21 Clinical Trial Not Allowed)
  (RFA-DA-25-010)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 14, 2024
  
  

• Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed)
  (RFA-DA-25-023)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 23, 2026
  
  

• Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental Health Sciences (R25 Clinical Trial Not Allowed)
  (RFA-ES-23-012)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): February 14, 2024
  
  

• Implementation of U.S. Food Safety Modernization Act - Identifying, Researching and Implementing Alternative Methods to Expand the Reach Across the Global Supply Chain (U01) - Clinical Trials Not Allowed
  (RFA-FD-24-013)
  Food and Drug Administration
  Application Receipt Date(s): February 19, 2024
  
  

• Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed
  (RFA-FD-24-014)
  Food and Drug Administration
  Application Receipt Date(s): February 19, 2024
  
  

• Natural History, Clinical Outcome Assessment, and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional
  (RFA-FD-24-024)
  Food and Drug Administration
  Application Receipt Date(s): May 06, 2024
  
  

• Streamlining mental health interventions for youth living with HIV in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
  (RFA-MH-25-140)
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): August 12, 2024